82 related articles for article (PubMed ID: 24314225)
1. [Association between urinary cadmium and clinicopathological characteristics of breast cancer].
Cen YL; Tang LY; Lin Y; Su FX; Wu BH; Ren ZF
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):632-5. PubMed ID: 24314225
[TBL] [Abstract][Full Text] [Related]
2. Modified effect of urinary cadmium on breast cancer risk by selenium.
Wei XL; He JR; Cen YL; Su Y; Chen LJ; Lin Y; Wu BH; Su FX; Tang LY; Ren ZF
Clin Chim Acta; 2015 Jan; 438():80-5. PubMed ID: 25149105
[TBL] [Abstract][Full Text] [Related]
3. Association between cadmium and breast cancer risk according to estrogen receptor and human epidermal growth factor receptor 2: epidemiological evidence.
Strumylaite L; Kregzdyte R; Bogusevicius A; Poskiene L; Baranauskiene D; Pranys D
Breast Cancer Res Treat; 2014 May; 145(1):225-32. PubMed ID: 24692081
[TBL] [Abstract][Full Text] [Related]
4. [Clinical features and prognosis analysis of different breast cancer molecular subtypes].
Yang Q; Chen J; Li HJ; Yu M; Tian CX; Lü Q
Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):42-6. PubMed ID: 21575463
[TBL] [Abstract][Full Text] [Related]
5. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
[TBL] [Abstract][Full Text] [Related]
7. Urinary rubidium in breast cancers.
Su Y; Chen LJ; He JR; Yuan XJ; Cen YL; Su FX; Tang LY; Zhang AH; Chen WQ; Lin Y; Wang SM; Ren ZF
Clin Chim Acta; 2011 Nov; 412(23-24):2305-9. PubMed ID: 21910977
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics and prognosis of different subtypes of breast cancer].
Yuan ZY; Wang SS; Zhu MQ; Zheng L; Luo WB; Zhou ZM; Guan ZZ
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):456-61. PubMed ID: 19024523
[TBL] [Abstract][Full Text] [Related]
11. [Correlations of HER-2, PCNA, Bcl-2, and Bax expression to prognosis of breast cancer].
Yang L; Zhu X; Ran L
Ai Zheng; 2007 Jul; 26(7):756-61. PubMed ID: 17626754
[TBL] [Abstract][Full Text] [Related]
12. Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer.
Huang HJ; Neven P; Drijkoningen M; Paridaens R; Wildiers H; Van Limbergen E; Berteloot P; Amant F; Vergote I; Christiaens MR
J Clin Pathol; 2005 Jun; 58(6):611-6. PubMed ID: 15917412
[TBL] [Abstract][Full Text] [Related]
13. Serum CD44 levels and overall survival in patients with HER2-positive breast cancer.
Baek JM; Jin Q; Ensor J; Boulbes DR; Esteva FJ
Breast Cancer Res Treat; 2011 Dec; 130(3):1029-36. PubMed ID: 21830016
[TBL] [Abstract][Full Text] [Related]
14. Cadmium exposure and breast cancer risk.
McElroy JA; Shafer MM; Trentham-Dietz A; Hampton JM; Newcomb PA
J Natl Cancer Inst; 2006 Jun; 98(12):869-73. PubMed ID: 16788160
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
Zhang HM; Zhang BN; Xuan LX; Zhao P
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.
Nguyen PL; Taghian AG; Katz MS; Niemierko A; Abi Raad RF; Boon WL; Bellon JR; Wong JS; Smith BL; Harris JR
J Clin Oncol; 2008 May; 26(14):2373-8. PubMed ID: 18413639
[TBL] [Abstract][Full Text] [Related]
17. Urinary cadmium and age-related macular degeneration.
Erie JC; Good JA; Butz JA; Hodge DO; Pulido JS
Am J Ophthalmol; 2007 Sep; 144(3):414-418. PubMed ID: 17631267
[TBL] [Abstract][Full Text] [Related]
18. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD
J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038
[TBL] [Abstract][Full Text] [Related]
19. A case-control study of the association between urinary cadmium concentration and endometriosis in infertile Japanese women.
Itoh H; Iwasaki M; Nakajima Y; Endo Y; Hanaoka T; Sasaki H; Tanaka T; Yang B; Tsugane S
Sci Total Environ; 2008 Sep; 402(2-3):171-5. PubMed ID: 18558423
[TBL] [Abstract][Full Text] [Related]
20. Frequency of HER-2/neu receptor positivity and its association with other features of breast cancer.
Naeem M; Nasir A; Aman Z; Ahmad T; Samad A
J Ayub Med Coll Abbottabad; 2008; 20(3):23-6. PubMed ID: 19610508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]